Telomerase Activation Sciences, CEO claimed two products could treat or prevent a range of age-related conditions
A company and its CEO who allegedly advertised and sold two “anti-aging” products using false or unsubstantiated claims have agreed to stop making the claims under a Federal Trade Commission settlement order

See the full post at FTC.gov